{"result": "(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>Harrison Principios de Medicina Interna is a medical textbook that provides comprehensive information on internal medicine, including various disorders and their treatments.)\n##\n(\"entity\"<|>UPTODATE<|>ORGANIZATION<|>UpToDate is a clinical decision support resource that provides evidence-based information on various medical topics, including the epidemiology and treatment of Cushing's syndrome.)\n##\n(\"entity\"<|>NIEMAN LK<|>PERSON<|>Nieman LK is a medical professional who has authored multiple reviews and guidelines on Cushing's syndrome and its management.)\n##\n(\"entity\"<|>CUSHING'S SYNDROME<|>EVENT<|>Cushing's syndrome is a hormonal disorder caused by prolonged exposure to high levels of cortisol, leading to various clinical manifestations and requiring specific diagnostic and treatment approaches.)\n##\n(\"entity\"<|>GLUCOCORTICOIDS<|>EVENT<|>Glucocorticoids are steroid hormones that play a role in the metabolism of carbohydrates, proteins, and fats, and are involved in the body's response to stress.)\n##\n(\"entity\"<|>DEXAMETHASONE<|>EVENT<|>Dexamethasone is a synthetic glucocorticoid used in the treatment of various conditions, including Cushing's syndrome, to suppress ACTH levels.)\n##\n(\"relationship\"<|>NIEMAN LK<|>UPTODATE<|>Nieman LK has contributed to UpToDate with literature reviews on Cushing's syndrome, providing valuable clinical insights<|>8)\n##\n(\"relationship\"<|>CUSHING'S SYNDROME<|>NIEMAN LK<|>Nieman LK has authored guidelines and reviews related to the diagnosis and treatment of Cushing's syndrome<|>9)\n##\n(\"relationship\"<|>CUSHING'S SYNDROME<|>DEXAMETHASONE<|>Dexamethasone is used as a treatment to manage Cushing's syndrome by suppressing ACTH levels<|>7)\n##\n(\"relationship\"<|>CUSHING'S SYNDROME<|>GLUCOCORTICOIDS<|>Cushing's syndrome is characterized by excess glucocorticoids, leading to various clinical symptoms<|>6)\n##\n(\"relationship\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>NIEMAN LK<|>Nieman LK's work is referenced in Harrison Principios de Medicina Interna, indicating his contributions to the field<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 50% de los pacientes tiene una ACTH a las 9 de la mañana dentro de los límites de referencia normal. En el 50% restante, se halla moderadamente elevada. La concentración de ACTH en el síndrome de ACTH ectópica es elevada; no obstante, se superpone con los valores observados en la enfermedad de Cushing en el 30% de los casos y, por consiguiente, no puede emplearse para diferenciar estas dos afecciones.\n\nReferencias:\n- Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.\n- Estrada J, Abad A, Aller J. Síndrome de Cushing. Manual de Endocrinología y Nutrición. Disponible en: https://manual.seen.es (última modificación: 25 de noviembre de 2015).\n- Nieman LK. Epidemiology and clinical manifestations of Cushing's syndrome. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com. Literature review current through: Apr. 2019.\n- Nieman LK. Establishing the diagnosis of Cushing's syndrome. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com. Literature review current through: Apr. 2019.\n- Nieman LK. Overview of the treatment of Cushing's syndrome. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com. Literature review current through: Apr. 2019.\n- Nieman LK, Biller BMK, Findiling JW, Murad MH, Newel-Price J, Savage MO, et al. Treatment of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100: 2807-31.\n- Nieman LK, Biller BMK, Findiling JW, Newel-Price J, Savage MO, Steward PM, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93:1526-40.\n- Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.\n\n## 13 En un caso de resistencia tisular a glucocorticoides, la secreción de ACTH estará:\n\nA. Disminuida.\nB. Permanentemente elevada.\nC. Normal, con pulsatilidad disminuida.\nD. Variable dependiendo de la actividad del feedback.\n\nCOMENTARIO\n\nLos pacientes con resistencia tisular a los glucocorticoides presentan características clínicas de exceso de andrógenos, de mineralocorticoides o de ambas hormonas. Los niveles de cortisol y de ACTH están elevados de manera constante, pero no existen estigmas del síndrome de Cushing. Estos pacientes se muestran resistentes a la supresión del cortisol con dosis bajas de dexametasona, pero responden con dosis altas de dexametasona.\n\nLos ritmos circadianos de la ACTH y del cortisol se hallan preservados en los pacientes con resistencia a los glucocorticoides. La elevación de ACTH provoca una mayor producción de andrógenos y de desoxicorticosterona (DOCA) que serán los causantes de la clínica asociada.\n\nEl tratamiento con una dosis de dexametasona suficiente para suprimir la ACTH (por lo general, 3 mg/día) permite la disminución de los andrógenos suprarrenales y el control de los valores de potasio y presión arterial.\n---\nSUPRARRENALES                                          5\n\nSe ha observado que muchos de estos pacientes tienen mutaciones en el dominio de fijación a los esteroides del receptor de glucocorticoides.\n\nEn pacientes con insuficiencia renal con filtrado glomerular estimado < 30 ml/min, la determinación de cortisol libre urinario no tiene valor.\n\nLos pacientes que presentan resistencia primaria al cortisol (o resistencia a los glucocorticoides), un raro síndrome familiar, muestran un aumento de la secreción de cortisol y de sus concentraciones plasmáticas, pero sin datos clínicos de hipercortisolismo. El síndrome se caracteriza por clínica de exceso de mineralocorticoides con concentraciones plasmáticas aumentadas de desoxicorticosterona (DOCA) y de andrógenos suprarrenales. Es probable que la hipertensión y la hipopotasemia se deban a los efectos combinados del exceso de DOCA y a un mayor acceso del cortisol al receptor de los mineralocorticoides por incapacidad de la 11-β-hidroxiesteroide deshidrogenasa tipo 2 para metabolizar todo el cortisol a nivel renal.\n\nEl sínd\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}